Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold

Stock Track05-15

Tango Therapeutics Inc. (TNGX) saw its stock price plummet 10.82% during intraday trading on Thursday, as the biopharmaceutical company faced significant selling pressure.

The sharp decline appears to be primarily driven by a rating change from investment firm Jefferies, which downgraded Tango Therapeutics from "Buy" to "Hold" while simultaneously raising its price target to $27 from $18. This mixed signal—a more cautious investment rating despite a higher valuation estimate—likely prompted investor concerns and triggered the sell-off.

Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating with a $30 target. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in today's trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103593580?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 01:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103593580","market":"us","top_or_hot":-1,"title":"Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold","media":"Stock Track","content":"<p>Tango Therapeutics Inc. (TNGX) saw its stock price plummet 10.82% during intraday trading on Thursday, as the biopharmaceutical company faced significant selling pressure.</p><p>The sharp decline appears to be primarily driven by a rating change from investment firm Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal—a more cautious investment rating despite a higher valuation estimate—likely prompted investor concerns and triggered the sell-off.</p><p>Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating with a $30 target. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in today's trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tango Therapeutics Plummets 10.82% Intraday Following Jefferies Downgrade to Hold\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-15 01:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tango Therapeutics Inc. (TNGX) saw its stock price plummet 10.82% during intraday trading on Thursday, as the biopharmaceutical company faced significant selling pressure.</p><p>The sharp decline appears to be primarily driven by a rating change from investment firm Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal—a more cautious investment rating despite a higher valuation estimate—likely prompted investor concerns and triggered the sell-off.</p><p>Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating with a $30 target. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in today's trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNGX","symbol_name":"Tango Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1103593580","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103593580","pubTimestamp":1778778185,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tango Therapeutics Inc. (TNGX) saw its stock price plummet 10.82% during intraday trading on Thursday, as the biopharmaceutical company faced significant selling pressure.The sharp decline appears to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNGX":"Tango Therapeutics Inc."},"translate_title":"个股追踪|Jefferies下调评级至持有后Tango Therapeutics盘中暴跌10.82%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNGX":1},"content_text":"Tango Therapeutics Inc. (TNGX) saw its stock price plummet 10.82% during intraday trading on Thursday, as the biopharmaceutical company faced significant selling pressure.The sharp decline appears to be primarily driven by a rating change from investment firm Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal—a more cautious investment rating despite a higher valuation estimate—likely prompted investor concerns and triggered the sell-off.Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating with a $30 target. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in today's trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103593580","isCrawlerRequest":true}